EGLN1 and breast cancer: lncRNA HIF-1α-stabilizing long noncoding RNA (HISLA) has been reported to suppress the interaction of PHD2 and HIF-1α to inhibit the hydroxylation and degradation of HIF-1α, leading to the regulation of aerobic glycolysis of breast cancer cells [41].